Keefe Bruyette lowered the firm’s price target on Bill (BILL) to $54 from $77 and keeps a Market Perform rating on the shares as part of a Q1 payments preview. Until there is more clarity on the macro backdrop, it is hard to see payments stocks outperforming meaningfully given the fear of potential downward revision to estimates, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BILL:
